S ummary: The circadian rhythms of preprandial and postprandial blood glucose, free fatty acids, and insulin levels were measured in groups of normal and of diabetic patients controlled by diet alone or by diet with tolbutamide, chlorpropamide, or metformin. All groups showed a greater insulin release after the first meal of the day than after subsequent meals. Diabetic patients con. trolled for more than two years on diguanide therapy showed the closest resemblance to non-diabetic control subjects. There was no significant difference between the values for diabetic patients on long-term control with diet alone and those on short-or long-acting sulphonylurea.
to inct ease the risk six times. Fundamental determining factors to puerperal thromboembolism are combinations of relative late age and traumatic delivery, and there may well be others such as obesity and hypertensive states complicating pregnancy. It still remains uncertain how often it is these which prompt the administration of oestrogens to inhibit lactation.
At this stage of knowledge it may be concluded that, provided oestrogens have the inhibitory effect on breast activity which is credited to them, and which our observations lead us to accept as genuine, their administration does not increase the risk of puerperal thromboembolism to an unacceptable degree. This is true for women at low risk, but for those who are advanced in years and who are subjected to operative delivery involving considerable trauma there is some reason to hesitate to add one more predisposing factor, even if it be a minor one. Obesity and a past history of thromboembolic disorders might also sometimes be considered to be contraindications to the administration of oestrogens in the puerperium. When oestrogens are given, however, it would seem wise to use the lowest dose compatible with efficient inhibition of lactation.
A firm conclusion about the role of therapeutic doses of oestrogen in predisposing to puerperal thromboembolism may not be possible without controlled prospective studies, and these are already in progress. Because the incidence of clinically evident disease is relatively low, this will take time. Meanwhile, the results of this retrospective study are reported to add to the evidence which needs to be collected from many sources.
Introduction
The aim of therapy of maturity onset diabetes with oral hypoglycaemic agents is to achieve good long-term diabetic " control " in patients who do not respond to dietary measures alone. Good control of blood glucose levels has been said to prevent the development of vascular complications (Marble, 1965) . Most studies of the action of hypoglycaemic agents have been concerned with the acute effect of the drug; there is little knowledge of what happens to patients in whom apparently good control is achieved over a prolonged period. Furthermore, possible differences between the available therapeutic agents have received little attention.
The present study was undertaken to document the changes of blood glucose, insulin, and free fatty acids in the fasting state and two hours after meals during the day in patients on different regimens (a restricted carbohydrate diet alone, or with tolbutamide, chlorpropamide, or metformin in addition), and to compare them with those found in normal persons and in obese patients undergoing total starvation. 
Patients and Methods
Six groups of patients were studied (Table I) . One of the two control groups consisted of three non-diabetic non-obese patients admitted to hospital for various medical conditions (simple goitre, Hashimoto's thyroiditis, cerebral angiospasm) who had a normal standard oral glucose tolerance test ; the other group consisted of six normoglycaemic obese subjects who were undergoing a period of therapeutic total starvation. There were four groups of diabetic patients on restricted carbohydrate diet, or a similar diet in addition to three different oral hypoglycaemic agents. We attempted to make these groups as comparable as possible. The mean age of the six groups varied from 51 to 69 years. Diabetes had been diagnosed from three to six years previously, and the patients had received their respective therapy unchanged for two to five years. The dosage of the drug used was that required to maintain satis- Hoffman, 1937) , insulin by the modified double antibody radio-immunoassay (Hales and Randle, 1963) , and plasma free fatty acids by the method of Duncombe (1964) . 
Results
The results from day 4 to day 6 have been pooled, as there was no difference in the mean values obtained between these days. Fig. 1 shows the variation of blood glucose, insulin, and free fatty acids in normal subjects, diabetic patients, and obese subjects on total starvation. In the normal controls' the blood sugar rose two hours after each meal, and was accommnied hv an Increase" i in ntaemA insulin pailcs;u uyt od aiiuitLwa-ns pioiis uasouu and a fall in free fatty acids. In the obese subjects on total starvation the blood glucose levels were slightly lower,' the insulin levels higher, and the free fatty acid levels considerably raised, but there was no evidence of any fluctuation during the period of observation. In the diabetic patients on diet alone the fasting blood glucose was 105 mg./100 ml., and rose to about 140 mg./100 ml. two hours after /\ i meals. The "insulinogenic index" (Seltzer et al., 1967) has been derived from these results for the two-hour period after breakfast (Table III) . 
Discussion
In a comparative study of this type between groups of different patients conclusions can only be tentative, but we feel that reasonable matching in regard to age, duration of disease, and therapy has been achieved. The group taking metformin was initially the most obese, but all the groups had lost weight to a relatively similar degree by the time of study.
The variation of insulin and free fatty acid levels after glucose loading in similar diabetic subjects has been reported by Abramson and Arky (1967) after only three weeks' therapy. They found a similar rise in plasma insulin after chlorpropamide and a relative decrease after phenformin therapy; the fall in free fatty acids showed no significant differences between these groups. However, Reaven and Dray (1967) stated that the control of hyperglycaemia by chlorpropamide therapy for a longer period was followed by a just significant fall in plasma insulin response after a glucose load. This study makes no reference to the possible weight changes that may have occurred by the time of the second test, and it may be that factors other than those attributable to the drug explain their findings. Sheldon et al. (1966) found a persistent increased insulin production in response to oral glucose two days after withdrawing acetohexamide following three months' therapy. Their study differs in that it probably represents a long-term effect on 13-cell function alone, whereas the present study is a composite of direct drug action and possible long-term changes in the insulin secretion apparatus.
Although the mean insulin levels are somewhat higher after meals in the two sulphonylurea-treated groups than in those on carbohydrate restriction alone, this difference does not reach significance, and probably represents only the slightly heavier weight and less good control of blood glucose in the groups in whom sulphonylureas had been prescribed. This finding is in keeping with the study of Chu et al. (1968) , who found, after five weeks of chlorpropamide therapy, no evidence of increase in insulin secretion independent of the usual physiological stimuli in comparison with pretreatment values.
It has been suggested from regression analysis of the relation between insulin and glucose levels (Seltzer et al., 1967 ) that a basic defect in diabetes is a diminished insulin secretion in response to a given rise in glucose: chlorpropamide therapy appears to make no difference to this impaired response, but to lower the level of hyperglycaemia at which it occurs (Chu et al., 1968) , suggesting that this drug enhances the sensitivity but not the response of the 13-cell. When the level of blood insulin obtained two hours after breakfast is related to the rise in blood glucose a comparison may be obtained with the figures of Seltzer et al. (who used a 100-g. glucose load after an overnight fast). The normal subjects give an index of 2.6 at two hours, which is less than that estimated from the data of Selter et al. (4.5) but consistent with a lesser glucose load. The " response " of the obese subjects who had no breakfast must be considered to show the variation of the method. The diabetic patients on diet alone show a lower index than the controls; those on sulphonylureas are also low, in keeping with the suggestion of Chu et al. (1968) . The apparently " normal " index in the patients taking metformin can be interpreted as being due to a lesser rise in blood glucose from enhanced peripheral utilization affording less requirement for insulin secretion. The figures derived from the after-lunch and after-tea values are less comparable owing to the shorter period of fasting. In general, the index obtained is lower than that after breakfast The present study was not designed to examine the individual patterns of insulin secretion after specific glucose loads, and these derived figures are presented only for purposes of comparison.
Weight reduction by dieting in obese diabetic patients produces a reduction in a previously excessive insulin response (Karam et al., 1965) , and this variable affects all such " before and after" studies. We have not studied our patients before the initiation of treatment. If it is assumed that the groups are comparable the results available do suggest that there is no useful difference in the long-term control achieved by diet alone or by diet with either of the commonly used sulphonylureas. The mean preprandial level of insulin in the more obese metformin-treated group is significantly lower than in the diabetics on diet alone, suggesting that the diguanide drugs may be preferable if long-term complications are shown to be related to circulating insulin concentration. Similar results have been reported in preliminary form for patients treated with phenformin (cited by Danowski, 1967) .
The greatest insulin response after the first of three equal meals during the day was consistently observed in all groups. This suggests that insulin synthesis and storage may proceed to a greater extent through the night than is possible in the short period between meals, and that the amount of insulin released may be determined not only by the carbohydrate load absorbed (Chu et al., 1968) but also by the amount of insulin which is available. 
MEDBIOU
In the obese patients on total starvation, free fatty acids were considerably raised without any variation throughout the day. Increase of free fatty acids during fasting in both obese and lean patients has been reported by Bloom et al. (1966) . A fall in plasma insulin to a mean of 8.3 tku./ml. during eight days' fasting in normal non-obese subjects was recorded by Cahill et al. (1966) . The raised levels still present in our own obese patients suggest that the response to starvation may be different between lean and obese subjects.
Treatment with diguanide drugs is known to result in a reduction in body weight of obese diabetic patients (Patel and Stowers, 1964; Schwartz et al., 1966) . Clarke and Duncan (1968) , in a carefully controlled long-term prospective study, found that most diabetic patients gained weight when taking chlorpropamide and tended to lose weight on metformin therapy. This is in keeping with our findings (Hadden et al., 1962) , where the mean change in weight in 150 patients treated for nine months or more with chlorpropamide was + 5.8 lb.
(+ 2.6 kg.). Nevertheless, there is no doubt that careful attention to diet will enable a satisfactory weight to be maintained regardless of additional sulphonylurea therapy, as shown by the satisfactory weight reduction of the patients in the present series who were taking the sulphonylurea drugs.
We are grateful to our colleague Dr. 
Methods and Materials
Vaccination was offered for children aged 6 months to 3 years; in the event, a small number who were younger than these also attended, and there were also a few who were up to 4 years old.
Each child was registered, and a numbered card was completed giving its name, age, and sex; a duplicate numbered card was given to the parent bringing the child.
After registration the first 191 children had pre-vaccination blood samples taken: these were obtained by finger-prick, and the sample was absorbed on to numbered filter-paper discs which contained 0.2 ml. of blood when fully saturated. The rest of the children attending were vaccinated (see below) but no pre-vaccination blood samples were taken.
After vaccination each child was given a suitable dose of pyrimethamine to prevent any attack of malaria during the period when vaccination reactions might be expected, and was told to return to the clinic in four weeks' time, bringing the duplicate registration card. Post-vaccination finger-prick blood samples were taken from all children who had been bled initially
